Login

Inozyme Pharma, Inc. SEC Filings

Filed On Filing
27 Aug 2025 SCHEDULE 13D/A
14 Aug 2025 SCHEDULE 13G/A
13 Aug 2025 SCHEDULE 13G/A
12 Aug 2025 SCHEDULE 13G/A
17 Jul 2025 SCHEDULE 13G/A
11 Jul 2025 15-12G
03 Jul 2025 Form 4: Subramanian Sanjay, SVP, CFO & Head of BD

Disposed of 39,701 shares (Tender Offer) ($159K) · Disposed of 38,500 Restricted Stock Units (Disposition to Issuer) · Disposed of 460,000 Stock Option (Right to Buy) (Disposition to Issuer)

03 Jul 2025 Form 4: Winton Matthew, COO

Disposed of 21,743 shares (Tender Offer) ($87K) · Disposed of 41,500 Restricted Stock Units (Disposition to Issuer) · Disposed of 145,000 Stock Option (Right to Buy) (Disposition to Issuer)

03 Jul 2025 Form 4: Bolte Axel, Director

Disposed of 423,926 shares (Tender Offer) ($1.7M) · Disposed of 393,363 Stock Option (Right to Buy) (Disposition to Issuer)

03 Jul 2025 Form 4: Sullivan Lynne Marie, Director

Disposed of 28,368 Stock Option (Right to Buy) (Disposition to Issuer)

03 Jul 2025 Form 4: Treco Douglas A, Director

Disposed of 43,861 shares (Tender Offer) ($175K) · Disposed of 150,000 Restricted Stock Units (Disposition to Issuer) · Disposed of 486,979 Stock Option (Right to Buy) (Disposition to Issuer)

03 Jul 2025 Form 4: Hopfner Robert Lorne, Director

Disposed of 4,494,851 shares (Tender Offer) ($18M)

01 Jul 2025 EFFECT
01 Jul 2025 EFFECT
01 Jul 2025 25-NSE
01 Jul 2025 S-8 POS
01 Jul 2025 S-8 POS
01 Jul 2025 S-8 POS
01 Jul 2025 S-8 POS
01 Jul 2025 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support